Encore Medical Education Will Publish the Best of SABCS(R) News From 2018 San Antonio Breast Cancer Symposium (SABCS)

Food and Healthcare Press Releases Monday December 3, 2018 14:58
SAN ANTONIO--3 Dec--PRNewswire/InfoQuest

Encore Medical Education will publish the Best of SABCS(R) News highlighting the key findings presented at the 41st San Antonio Breast Cancer Symposium (SABCS(R)), to be held on December 4-8, 2018 in San Antonio, Texas, USA. The Best of SABCS(R) News English website (http://www.bestofsabcsnews.com) will cover official expert video news highlights of key clinical trials each day on various topics, including:

  • Results from the TAILORx trial Psoriasis
  • Primary results from KATHERINE
  • Efficacy results from CIBOMA/2004-01_GEICAM/2003-11 study
  • RAPID: A randomized trial of accelerated partial breast irradiation using 3-dimensional conformal radiotherapy (3D-CRT)
  • The Year in Review
  • Interim Analysis from the Randomized SUCCESS C Study
  • The impact of breast cancer surgery on quality of life: Long term results from E5103
  • Skin wrinkling and aging
  • And many others…
(Logo: https://mma.prnewswire.com/media/792198/Encore_Medical_Education_SABCS_Logo.jpg )
You can now register for free on http://www.bestofsabcsnews.com . The official expert video news will be available starting December 6, 2018 at 4:00 pm CDT (UTC -6).
Other Best of SABCS(R) News local programs available on https://www.bestofsabcs.com/best-of-sabcs-news/ in 2018:
  • The Best of SABCS(R) News program in German
  • The Best of SABCS(R) News program in Spanish
  • The Best of SABCS(R) News program in Japanese
About Best of SABCS(R) programs

The San Antonio Breast Cancer Symposium(R), now in its 41st year, is the premier conference for basic, translational, and clinical cancer research professionals. It is well-known for presenting the latest breast cancer data from all over the world.

The Best of SABCS(R) program is an officially licensed program offering the actual presentations and posters from the annual SABCS(R). Best of SABCS(R) programs offer professionals who are unable to travel to San Antonio the opportunity to experience and discuss the most current research and advances in the field of breast cancer with colleagues and key opinion leaders.

For further information on sponsorship opportunities, please contact Encore Medical Education LLC, the exclusive agent of the SABCS(R) for the dissemination of the Annual Meeting content internationally, at lidia.martin@encoremeded.com

Lidia Martin
Alex DeNovoa
Source: Encore Medical Education

Latest Press Release

Menicon Announces Launch of Menicon Bloom Myopia Control Management System

- Launch Features Initial Introduction of Menicon Bloom Night, First and Only CE-approved Orthokeratology Contact Lens in Europe for Myopia Control - Menicon Co., Ltd. announced on May 24 the launch of the Menicon Bloom Myopia Control Management System,...

Experts Discuss Decentralized Manufacturing to Tackle Neglected Tropical Diseases and Promote Universal Health Coverage at World Health Assembly Event

- Global health leaders covered biomanufacturing and neglected tropical diseases (NTDs) during 72nd World Health Assembly - Event focused on innovative science and technology-based solutions to increase access to medicines and biologics Merck, a...

Menarini Ricerche at the ASCO Annual Meeting 2019 With Three Different Projects in Oncology

Menarini Ricerche will present three different projects related to the compounds in clinical development SEL24/MEN1703, MEN1611 and MEN1309/OBT076 at the ASCO Annual Meeting 2019 in Chicago. During the poster session "Breast Cancer – Metastatic"...

Surgical Specialties Corporation Launches Caliber Ophthalmics Division to Focus on Global Growth of Ophthalmic Surgical Procedures

Surgical Specialties Corporation (SSC) announced today the launch of Caliber Ophthalmics, a new business division. Caliber Ophthalmics combines SSC's Sharpoint(TM) brand, which has earned a trusted reputation serving ophthalmic surgeons for over 50...

After $7.1 Billion Sale Of Frutarom, Ori Yehudai To Join The Sade Group As Active Chairman and Investor

Ori Yehudai: "I took a company worth $3 million and sold it to IFF at $7.1 billion in 2018. In my opinion, the success of our cannabis company will be to build an industrial pharmaceutical company with the strictest standards, we had two such plants, and...

Related Topics